Clinical Trial Update: A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes. [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study by Hoffmann-La Roche evaluating how renal impairment affects the activity of GK Activator (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GK Activator (2)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED